ciprofloxacin has been researched along with Scleroma, Nasal in 15 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Klebsiella rhinoscleromatis is the causative agent of this infection and the Mikulicz cell is specific to the lesion being a large macrophage with clear cytoplasm containing the bacilli." | 5.31 | A case of rhinoscleroma treated with ciprofloxacin. ( Badia, L; Lund, VJ, 2001) |
| "Rhinoscleroma is a granulomatous infection of the nasal cavities due to enteric bacterium belonging to the Klebsiella family (Klebsiella rhinoscleromatis)." | 1.48 | [Rhinoscleroma: a rare chronic infection of the nasal cavities]. ( Ghorbel, AM; Kallel, S, 2018) |
| "Rhinoscleroma is a chronic infectious disease that is endemic in certain poor areas of the world." | 1.48 | Rhinoscleroma: a chronic infectious disease of poor areas with characteristic histological features - report of a series of six cases. ( Ben Mansour, N; Chbani, L; Efared, B; El Fatemi, H; Gabrielle, AE; Hammas, N, 2018) |
| "Rhinoscleroma is a specific granulomatous and chronic disorder with insidious evolution." | 1.48 | [Rhinoscleroma of the cavum with expression in cervical lymph nodes: about a case]. ( Benayad, J; Benbouzid, MA; El Ayoubi, A; Essakalli, L; Lachhab, O; Lassikri, O, 2018) |
| "Klebsiella rhinoscleromatis is the causative agent of this infection and Mikulicz cells are specific to this lesion." | 1.42 | Rhinoscleroma of nose extruding into oral cavity. ( Desai, D; Ingaleshwar, PS; K V, S; Nayak, P; Pandit, S; R C, P, 2015) |
| "Rhinoscleroma is a chronic, slowly progressive, inflammatory disease of the upper respiratory tract." | 1.38 | Rhinoscleroma: a case series. ( Neoh, CY; Tan, HH; Tan, SL, 2012) |
| "Rhinoscleroma has become a more and more rare disease because of the sensitivity to the new molecules." | 1.37 | Retrospective study of the rhinoscleroma about 14 cases in ENT departments of university hospitals (Côte d'Ivoire). ( Kacouchia, N; Koffi-N'guessan, L; Kouassi, M; Kouassi-Ndjeundo, J; Mobio, NM; N'gattia, KV; Vroh Bi, TS; Yoda, M, 2011) |
| "Klebsiella rhinoscleromatis is the causative agent of this infection and the Mikulicz cell is specific to the lesion being a large macrophage with clear cytoplasm containing the bacilli." | 1.31 | A case of rhinoscleroma treated with ciprofloxacin. ( Badia, L; Lund, VJ, 2001) |
| "Rhinoscleroma is a very rare cause of upper airway obstruction with only isolated reports in the literature of rhinoscleroma with isolated tracheal obstruction." | 1.31 | Upper airway obstruction due to rhinoscleroma: case report. ( Al Jahdali, H; Al Othman, A; Al-Zuwayed, M; Bamefleh, H; Memish, Z, 2001) |
| "Rhinoscleroma is a rare infectious disease of the upper respiratory tract caused by Klebsiella rhinoscleromatis." | 1.30 | [Rhinoscleroma: a case report]. ( Bodlaj, R; Issing, WJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sadek, HS | 1 |
| El-Marssafy, LH | 1 |
| Hussein, FF | 1 |
| Kallel, S | 1 |
| Ghorbel, AM | 1 |
| Gamea, M | 1 |
| El Tatawi, F | 1 |
| Elnaggar, A | 1 |
| Elafandi, H | 1 |
| Ebeid, K | 1 |
| Efared, B | 1 |
| Hammas, N | 1 |
| Gabrielle, AE | 1 |
| Ben Mansour, N | 1 |
| El Fatemi, H | 1 |
| Chbani, L | 1 |
| Lassikri, O | 1 |
| Benayad, J | 1 |
| Lachhab, O | 1 |
| El Ayoubi, A | 1 |
| Benbouzid, MA | 1 |
| Essakalli, L | 1 |
| Nayak, P | 1 |
| R C, P | 1 |
| K V, S | 1 |
| Desai, D | 1 |
| Pandit, S | 1 |
| Ingaleshwar, PS | 1 |
| Ramachandran, P | 1 |
| Piquette, C | 1 |
| Poole, JA | 1 |
| N'gattia, KV | 1 |
| Kacouchia, N | 1 |
| Koffi-N'guessan, L | 1 |
| Mobio, NM | 1 |
| Kouassi-Ndjeundo, J | 1 |
| Kouassi, M | 1 |
| Yoda, M | 1 |
| Vroh Bi, TS | 1 |
| Tan, SL | 1 |
| Neoh, CY | 1 |
| Tan, HH | 1 |
| Avery, RK | 1 |
| Salman, SD | 1 |
| Baker, AS | 1 |
| Borgstein, J | 1 |
| Sada, E | 1 |
| Cortes, R | 1 |
| Issing, WJ | 1 |
| Bodlaj, R | 1 |
| Fajardo-Dolci, G | 1 |
| Chavolla, R | 1 |
| Lamadrid-Bautista, E | 1 |
| Rizo-Alvarez, J | 1 |
| Badia, L | 1 |
| Lund, VJ | 1 |
| Al Jahdali, H | 1 |
| Bamefleh, H | 1 |
| Memish, Z | 1 |
| Al-Zuwayed, M | 1 |
| Al Othman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gemifloxacin Versus Ciprofloxacin Versus Rifampicin in Treatment of Rhinoscleroma[NCT03326050] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2018-02-28 | Not yet recruiting | ||
| Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma[NCT05431673] | Phase 1 | 45 participants (Anticipated) | Interventional | 2022-08-21 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ciprofloxacin and Scleroma, Nasal
| Article | Year |
|---|---|
Ciprofloxacin for rhinoscleroma and ozena.
Topics: Ciprofloxacin; Female; Humans; Male; Rhinitis, Atrophic; Rhinoscleroma; Rifampin; Trimethoprim, Sulf | 1993 |
14 other studies available for ciprofloxacin and Scleroma, Nasal
| Article | Year |
|---|---|
First report of rare persistence granulomatous extra respiratory Rhinoscleroma of oral pathology.
Topics: Ciprofloxacin; Female; Humans; Nasal Cavity; Nose; Pathology, Oral; Rhinoscleroma | 2022 |
[Rhinoscleroma: a rare chronic infection of the nasal cavities].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Female; Humans; Klebsiella pneumoni | 2018 |
Topical ciprofloxacin as treatment for rhinoscleroma in a series of 23 patients.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Ma | 2021 |
Rhinoscleroma: a chronic infectious disease of poor areas with characteristic histological features - report of a series of six cases.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Chronic Disease; Ciprofloxacin; Female; Humans; Mal | 2018 |
[Rhinoscleroma of the cavum with expression in cervical lymph nodes: about a case].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Female; Follow-Up Studies; Humans; Klebsiella pneumoniae; Lymp | 2018 |
Rhinoscleroma of nose extruding into oral cavity.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Middle Aged; Mouth; Nas | 2015 |
Rhinoscleroma in a young adult with chronic rhinitis and dyspnea.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Dyspnea; Female; Humans; Klebsiella pneumoniae; Nasal O | 2008 |
Retrospective study of the rhinoscleroma about 14 cases in ENT departments of university hospitals (Côte d'Ivoire).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality | 2011 |
Rhinoscleroma: a case series.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; | 2012 |
Rhinoscleroma treated with ciprofloxacin: a case report.
Topics: Adult; Ciprofloxacin; Humans; Male; Rhinoscleroma; Treatment Outcome | 1995 |
[Rhinoscleroma: a case report].
Topics: Adult; Ciprofloxacin; Combined Modality Therapy; Endoscopy; Humans; Klebsiella pneumoniae; Male; Nas | 1999 |
Laryngeal scleroma.
Topics: Adult; Airway Obstruction; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Laryngeal Diseases; | 1999 |
A case of rhinoscleroma treated with ciprofloxacin.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Magnetic Resonance Imaging; Rhinos | 2001 |
Upper airway obstruction due to rhinoscleroma: case report.
Topics: Airway Obstruction; Anti-Infective Agents; Bronchoscopy; Ciprofloxacin; Dyspnea; Female; Gram-Negati | 2001 |